Jazz Pharmaceuticals (JAZZ)

Company Ticker Sector | Industry Quality PAR
Jazz Pharmaceuticals JAZZ Healthcare | Biotechnology 95 19.2%
Current Price (02/27) $113.10
CAPS Rating (Rate this stock on CAPS) Foolcaps 3
Expected Income Statement
Current Sales 2,056.5
Sales Growth Forecast 11.5%
Net Profit Margin 47.6%
Projected Shares Outstanding 61.99
EPS - Five year Forecast $27.25
Average P/E Ratio 10.0
Projected Average Price $272.52
Price Appreciation (Annualized) 19.2%
Annual Dividend Yield 0.0%
Projected Annual Return 19.2%
Quality
Financial Strength 95 23.7
EPS Stability 95 23.8
Industry Sales Growth Rate 16.5% 8.7
Industry Net Profit Margin 29.0% 20.5
Calculated Quality Rating 76.7
Fool CAPS

Total Players

289 Outperforms
67 Underperforms
 

All-Stars (53)

40 Outperforms (75%)
13 Underperforms
 
Fundamental Data Updated: 01/31/2020

MIPAR 10.8%  
Sweet Spot 15.8% - 20.8%  

Top In Biotechnology

Ticker Quality PAR
JAZZ 95 19.2%
REGN 81 18.8%
BIIB 75 13.8%
AMGN 88 10.5%
CBPO 72 13.2%

Top In Healthcare

Ticker Quality PAR
ALGN 98 19.6%
JAZZ 95 19.2%
ABBV 91 19.2%
UNH 96 15.8%
REGN 81 18.8%